Gasang, Harlene I.
HRN: 22-28-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFUROXIME 500MG (TAB)
12/27/2022
01/02/2023
PO
500
Bid
Repeat LSCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes